Vivos Therapeutics (VVOS) intends to raise $20 million in an IPO of its common stock, according to an S-1 registration statement.
Highlands Ranch, Colorado-based Vivos was founded to develop customized oral devices designed to help people who suffer from mild to moderate obstructive sleep apnea [OSA].
Management is headed by co-founder, Chairman and CEO R. Kirk Huntsman, who was previously founder of Dental One Partners, a large dental service organization.
Below is a brief overview video of Vivos Therapeutics:
The company’s primary offering is the Vivos System, composed of a nighttime appliance and a daytime/nighttime appliance.
Vivos has received at least $21 million from investors.
The firm sells its systems to dental practitioners via a direct sales force that targets prospects in the U.S. and Canada.
In the future, and with some of the proceeds from the IPO, the firm intends to develop strategic partnerships, connect with key opinion leaders,